Literature DB >> 8487045

Back to the basics: the importance of concentration x time in oncology.

S D Weitman, E Glatstein, B A Kamen.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8487045     DOI： 10.1200/JCO.1993.11.5.820

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy.

Authors:  Heinz Schättler; Urszula Ledzewicz; Behrooz Amini
Journal:  J Math Biol       Date:  2015-06-19       Impact factor: 2.259

2.  Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology.

Authors:  Eddy Pasquier; Mark W Kieran; Jaroslav Sterba; Yuval Shaked; Sylvain Baruchel; Odile Oberlin; Maria Sanna Kivivuori; Andreas Peyrl; Mamouna Diawarra; Michaela Casanova; Stergios Zacharoulis; Gilles Vassal; Franck Berthold; Arnauld Verschuur; Nicolas André
Journal:  Transl Oncol       Date:  2011-08-01       Impact factor: 4.243

3.  Chemotherapeutic dosing implicated by pharmacodynamic modeling of in vitro cytotoxic data: a case study of paclitaxel.

Authors:  Hua He; Yanguang Cao
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-08-31       Impact factor: 2.745

4.  Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics.

Authors:  Philip Hahnfeldt; Lynn Hlatky; Giannoula Lakka Klement
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

5.  Quality of pharmacokinetic research in oncology.

Authors:  J Siderov; J E Brien; D J Morgan; J Zalcberg; W Cosolo
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

Review 6.  Metronomic chemotherapy.

Authors:  Rituparna Maiti
Journal:  J Pharmacol Pharmacother       Date:  2014-07

7.  Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells.

Authors:  Ursula Winter; Hebe A Mena; Soledad Negrotto; Eloisa Arana; Guillem Pascual-Pasto; Viviana Laurent; Mariona Suñol; Guillermo L Chantada; Angel M Carcaboso; Paula Schaiquevich
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

8.  A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer.

Authors:  Min Shi; Tao Ma; Wenqi Xi; Jinling Jiang; Junwei Wu; Chenfei Zhou; Chen Yang; Zhenggang Zhu; Jun Zhang
Journal:  Trials       Date:  2020-03-06       Impact factor: 2.279
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.